The retail giant’s initiative to offer attractive pay in every market they operate reflects in the pay raise of all associates. The average salary for pharmacists is now more than $140,000, not including bonuses and incentives. After investments within the optician and vision department, it’s expected the average wage for opticians to be more than $22.50 an hour.
Coherus will launch Yusimry in July with a list price of $995 per carton (2 x 40 mg/0.8 mL autoinjectors); “the lowest price announced to date of any adalimumab offering in the United States,” the company said.
Eligible members can enroll into these programs through Virta and Omada Health tools under Capital. The programs are personalized for Capital members on an easy-to-use app offering one-on-one health coaching, medical tools, community support, activity tracking and more.
The drugs must have full “traditional” FDA approval and patients need to be enrolled in a registry that collects post-approval data efficacy and safety when the drugs are used in clinical practice.
Understanding whether the prevention of RSV infection during infancy can reduce the risk of childhood asthma is key to designing successful and preventive strategies, preventing long-term childhood respiratory morbidity, and outlining healthcare policy measures.
Respiratory syncytial virus (RSV) can be deadly for the very young and the old and frail. GSK's vaccine will be marketed under the brand name Arexvy and Pfizer's under the name Abrysvo.
Miebo is the first and only prescription eye drop approved for dry eye disease (DED) that directly targets tear evaporation.
The head of a gastroenterologist group criticizes the company for having a "slapdash approach."
Lifileucel is a polyclonal tumor infiltrating lymphocyte (TIL) therapy designed for patients with advanced melanoma who have experienced progression after previous treatment with anti-PD-1/L1 therapy and targeted therapy.
Bowing to political and public pressure, insulin makers have slashed their prices. So far, insulin biosimilars haven’t had much of an effect on prices.
Editors are searching for diverse healthcare professionals from different backgrounds and healthcare sectors, with individual interests, and so on. Candidates should have, but not limited to, 12 years or fewer experience in healthcare.
Inpefa (sotagliflozin) is in the SGLT inhibitor class recommended as first-line treatment for heart failure by the American Heart Association and other groups. Jardiance (empaglifozin), a competitor in that class, has a list price of $570.48 for a month's supply.
Dated notions and lack of an early connection to healthcare keep men from seeking care.
The Biden-McCarthy leaves $5 billion intact for coronavirus vaccine and treatment research, according to multiple media reports.
The World Health Organization shared its enthusiasm for the “appropriate” use of these technologies. However, they are calling for caution to be exercised to protect and promote human well-being, safety, and autonomy and preserve public health.
The purpose of the federal vaccine safety reporting system often is misunderstood, and its data can be easily used to spread false information about vaccination. A new report from the Annenberg Public Policy Center at the University of Pennsylvania looks at how it was manipulated to raise doubts about COVID-19 vaccines and suggests remedies.
At the start of the pandemic, the government eased rules around prescribing drugs via the internet. Now it is deciding what the permanent rules should be.
The federal government is extending pandemic-era “flexibility” for telehealth prescriptions.
The frequency of drug manufacturer coupon utilization is associated with more market competition—but not patients’ out-of-pocket costs.
The company said 21% of its Medicare Advantage members are in plans with 2023 ratings of 4.0 or above, a steep decline from the 2023 star ratings.
The announcement mentions the growth in Medicare Advantage during his five-year tenure.
More than 11.6 million treatment courses of the medication have been prescribed in the U.S. to date.
AbbVie and Genmab have set a price for newly approved Epkinly (epcoritamab-bysp).
The FDA recently approved Brixadi to treat moderate to severe opioid use disorder in patients who have already started treatment with a transmucosal form of buprenorphine, and have approved Opvee as an emergency treatment to reverse known or suspected opioid overdose in people ages 12 years and older.
Iowa's Department of Health and Human Services, which manages the two health insurers that delivered care to adults and children in the state’s Medicaid program last year, was alleged to provide inadequate mental and behavioral health care to children on Medicaid.
Since 2017, two lawsuits and two state audits have cast a harsh light on Medicaid managed care, which served 845,000 adults and children at a cost of almost $6 billion last year.
The Cyltezo Pen is scheduled to be on the market and available on July 1.
Labs are justifying larger respiratory panels as simplifying a physician’s job in diagnosing via lab testing, but payers need to observe the multiplex testing trend.
Seasonal influenza kills hundreds of thousands of people every year due to a constantly changing virus and highly inefficient vaccine production. A universal flu vaccine could deal with the first problem, and mRNA technology with the second.
Eric Hunter, president and CEO of CareOregon, and editorial advisory board member of Managed Healthcare Executive, talks with MHE about the “combination” underway between CareOrgeon and SCAN Health and how it's a good thing amid the concerns it would make CareOregon less responsive to local needs. Hunter also talks about how the combination will affect how they manage pharmacy benefits, and what else is on their radar in healthcare.
